This article is available online at http://www.jlr.orgTestosterone , a steroid hormone with an important role in male sexual differentiation, maintenance of libido, and erectile function ( 1, 2 ), is also a central modulator of key metabolic processes associated with metabolic syndrome. In humans, testosterone defi ciency (TD) alters carbohydrate, lipid, and protein metabolism, thus contributing to oxidative stress, endothelial dysfunction, and increased production of proinfl ammatory factors ( 3 ). TD is considered as a primary risk factor for a number of disorders including obesity, metabolic syndrome, dyslipidemia, endothelial cell dysfunction, vascular disease, insulin resistance, and type 2 diabetes mellitus ( 4-8 ). Likewise, data from the Massachusetts Male Aging Study suggest that obesity leads to decreased levels of total and free testosterone, with follow-up levels lowest among men who remained or became obese ( 9 ).Additional insights into the role of androgens in maintaining human health have been obtained following androgen deprivation therapy (ADT), which is often used in the treatment of prostate cancer (PCa). Metabolic complications of ADT, such as metabolic syndrome, insulin resistance, and type 2 diabetes mellitus have highlighted key avenues of human pathology associated with this treatment ( 10 ). ADT in men with PCa resulted in increased total cholesterol, LDL cholesterol (LDL-C), and TG levels ( 11, 12 ). Abbreviations: ADT , androgen deprivation therapy; AUC, area under the curve; BAT, brown adipose tissue; Cox4, cytochrome c oxidase subunit 4; EE, energy expenditure; GTT, glucose tolerance test; hCetp, human cholesteryl ester transfer protein; HDL-C, HDL cholesterol; LBM, lean body mass; Ldlr, LDL receptor; Lrp1, LDL receptor-related protein 1; PCa, prostate cancer; RER, respiratory exchange ratio; TD, testosterone defi ciency; Ucp1, uncoupling protein 1; VCO 2 , carbon dioxide production expressed as the difference of carbon dioxide exiting from carbon dioxide entering the metabolic cage; VO 2 , oxygen consumption expressed as the difference between oxygen entering and oxygen exiting the metabolic cage; WAT, white adipose tissue.